Please follow the link below to access Pathology State of Affairs: Underscoring the Value of Biomarker Testing for Solid Tumors on Medscape's website. This program was developed through the collaboration between the United States and Canadian Academy of Pathology (USCAP) and Medscape.
Authors: Fred R. Hirsch, MD, PhD
CME / ABIM MOC Released: 9/16/2022
Valid for credit through: 9/16/2023
Target Audience and Goal StatementThis activity is intended for pathologists, oncologists, surgeons, and other healthcare professionals participating in the care of patients with solid tumors.
The goal of this activity is that learners will be better able to identify biomarkers in patients with solid tumors.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Characteristics of biomarkers found in patients with solid tumors
- Methodologies used to detect biomarkers in patients with solid tumors
- Have greater competence related to
- Identifying biomarkers in patients with solid tumors
Developed through a partnership between Medscape and USCAP.
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.